Discontinued — last reported Q1 '19
Boston Scientific Amortization expense increased by 1.3% to $228.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 1.8%, from $224.00M to $228.00M. Over 4 years (FY 2021 to FY 2025), Amortization expense shows an upward trend with a 4.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase typically follows major acquisitions, while a steady decline indicates the aging of the intangible asset portfolio.
The systematic allocation of the cost of intangible assets, such as acquired customer lists or brand value, over their e...
Common in companies with a history of M&A; peers with similar acquisition profiles will show comparable trends.
is_cat_amortization_expense| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $180.00M | $184.00M | $192.00M | $198.00M | $204.00M | $202.00M | $199.00M | $203.00M | $210.00M | $208.00M | $207.00M | $214.00M | $213.00M | $205.00M | $224.00M | $219.00M | $225.00M | $225.00M | $228.00M |
| QoQ Change | — | +2.2% | +4.3% | +3.1% | +3.0% | -1.0% | -1.5% | +2.0% | +3.4% | -1.0% | -0.5% | +3.4% | -0.5% | -3.8% | +9.3% | -2.2% | +2.7% | +0.0% | +1.3% |
| YoY Change | — | — | — | — | +13.3% | +9.8% | +3.6% | +2.5% | +2.9% | +3.0% | +4.0% | +5.4% | +1.4% | -1.4% | +8.2% | +2.3% | +5.6% | +9.8% | +1.8% |